お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は再生医療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは再生医療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の再生医療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは再生医療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に再生医療市場を分類しています。本研究に含まれる主な企業は：J & J (DePuy Synthes)、Medtronic、Zimmer Biomet、Stryker、Allergan(Acelity)、MiMedx Group、Organogenesis、Fujifilm Cellular Dynamics、Osiris Therapeutics、Vcanbio、CCBC、Cytori、Celgene、Vericel Corporation、Guanhao Biotech、Mesoblast、AMAG Pharmaceuticals (CBR)、ViaCord、CordLife、Integra LifeSciences、Nuvasive、Cook Biotech、Japan Tissue Engineering

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Cell Therapy
    Tissue Engineering
    Biomaterial
    Other

用途別の市場セグメント：
    Dermatology
    Cardiovascular
    CNS
    Orthopedic
    Others

本レポートの詳細内容
世界の再生医療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、再生医療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の再生医療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の再生医療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、再生医療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

再生医療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：再生医療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：再生医療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章再生医療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：再生医療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：再生医療の主要企業の概要を提供し、製品の説明と仕様、再生医療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.
Regenerative medicine is defined as the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function and has been called the "next evolution of medical treatments" and “the vanguard of 21st century healthcare” by the U.S. Department of Health and Human Services.
Market Analysis and Insights: Global Regenerative Medicine Market
The global Regenerative Medicine market is projected to grow from US$ 40320 million in 2024 to US$ 115660 million by 2030, at a Compound Annual Growth Rate (CAGR) of 19.2% during the forecast period.
Global Regenerative Medicine key players include J & J (DePuy Synthes), Medtronic, Allergan(Acelity), Zimmer Biomet, etc. Global top four manufacturers hold a share about 10%.
North America is the largest market, with a share about 25%, followed by Europe, and Asia Pacific, both have a share over 40 percent. 
In terms of product, Tissue Engineering is the largest segment, with a share over 40%. And in terms of application, the largest application is Dermatology, followed by Cardiovascular, CNS, Orthopedic, etc.
Report Covers:
This report presents an overview of global market for Regenerative Medicine market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Regenerative Medicine, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Regenerative Medicine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Regenerative Medicine revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Regenerative Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Regenerative Medicine revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
    J & J (DePuy Synthes)
    Medtronic
    Zimmer Biomet
    Stryker
    Allergan(Acelity)
    MiMedx Group
    Organogenesis
    Fujifilm Cellular Dynamics
    Osiris Therapeutics
    Vcanbio
    CCBC
    Cytori
    Celgene
    Vericel Corporation
    Guanhao Biotech
    Mesoblast
    AMAG Pharmaceuticals (CBR)
    ViaCord
    CordLife
    Integra LifeSciences
    Nuvasive
    Cook Biotech
    Japan Tissue Engineering

Segment by Type
    Cell Therapy
    Tissue Engineering
    Biomaterial
    Other

Segment by Application
    Dermatology
    Cardiovascular
    CNS
    Orthopedic
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Regenerative Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Regenerative Medicine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Regenerative Medicine revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Regenerative Medicine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Cell Therapy
    Table 3. Key Players of Tissue Engineering
    Table 4. Key Players of Biomaterial
    Table 5. Key Players of Other
    Table 6. Global Regenerative Medicine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Regenerative Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Regenerative Medicine Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Regenerative Medicine Market Share by Region (2019-2024)
    Table 10. Global Regenerative Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Regenerative Medicine Market Share by Region (2025-2030)
    Table 12. Regenerative Medicine Market Trends
    Table 13. Regenerative Medicine Market Drivers
    Table 14. Regenerative Medicine Market Challenges
    Table 15. Regenerative Medicine Market Restraints
    Table 16. Global Regenerative Medicine Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Regenerative Medicine Revenue Share by Players (2019-2024)
    Table 18. Global Top Regenerative Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2023)
    Table 19. Global Regenerative Medicine Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Regenerative Medicine Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Regenerative Medicine, Headquarters and Area Served
    Table 22. Global Key Players of Regenerative Medicine, Product and Application
    Table 23. Global Key Players of Regenerative Medicine, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Regenerative Medicine Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Regenerative Medicine Revenue Market Share by Type (2019-2024)
    Table 27. Global Regenerative Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Regenerative Medicine Revenue Market Share by Type (2025-2030)
    Table 29. Global Regenerative Medicine Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Regenerative Medicine Revenue Share by Application (2019-2024)
    Table 31. Global Regenerative Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Regenerative Medicine Revenue Share by Application (2025-2030)
    Table 33. North America Regenerative Medicine Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Regenerative Medicine Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Regenerative Medicine Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Regenerative Medicine Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Regenerative Medicine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Regenerative Medicine Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Regenerative Medicine Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Regenerative Medicine Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Regenerative Medicine Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Regenerative Medicine Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Regenerative Medicine Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Regenerative Medicine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Regenerative Medicine Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Regenerative Medicine Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Regenerative Medicine Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Regenerative Medicine Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Regenerative Medicine Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Regenerative Medicine Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Regenerative Medicine Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Regenerative Medicine Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Regenerative Medicine Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Regenerative Medicine Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Regenerative Medicine Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Regenerative Medicine Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Regenerative Medicine Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Regenerative Medicine Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Regenerative Medicine Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Regenerative Medicine Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Regenerative Medicine Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Regenerative Medicine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Regenerative Medicine Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Regenerative Medicine Market Size by Country (2025-2030) & (US$ Million)
    Table 65. J & J (DePuy Synthes) Company Details
    Table 66. J & J (DePuy Synthes) Business Overview
    Table 67. J & J (DePuy Synthes) Regenerative Medicine Product
    Table 68. J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 69. J & J (DePuy Synthes) Recent Developments
    Table 70. Medtronic Company Details
    Table 71. Medtronic Business Overview
    Table 72. Medtronic Regenerative Medicine Product
    Table 73. Medtronic Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 74. Medtronic Recent Developments
    Table 75. Zimmer Biomet Company Details
    Table 76. Zimmer Biomet Business Overview
    Table 77. Zimmer Biomet Regenerative Medicine Product
    Table 78. Zimmer Biomet Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 79. Zimmer Biomet Recent Developments
    Table 80. Stryker Company Details
    Table 81. Stryker Business Overview
    Table 82. Stryker Regenerative Medicine Product
    Table 83. Stryker Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 84. Stryker Recent Developments
    Table 85. Allergan(Acelity) Company Details
    Table 86. Allergan(Acelity) Business Overview
    Table 87. Allergan(Acelity) Regenerative Medicine Product
    Table 88. Allergan(Acelity) Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 89. Allergan(Acelity) Recent Developments
    Table 90. MiMedx Group Company Details
    Table 91. MiMedx Group Business Overview
    Table 92. MiMedx Group Regenerative Medicine Product
    Table 93. MiMedx Group Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 94. MiMedx Group Recent Developments
    Table 95. Organogenesis Company Details
    Table 96. Organogenesis Business Overview
    Table 97. Organogenesis Regenerative Medicine Product
    Table 98. Organogenesis Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 99. Organogenesis Recent Developments
    Table 100. Fujifilm Cellular Dynamics Company Details
    Table 101. Fujifilm Cellular Dynamics Business Overview
    Table 102. Fujifilm Cellular Dynamics Regenerative Medicine Product
    Table 103. Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 104. Fujifilm Cellular Dynamics Recent Developments
    Table 105. Osiris Therapeutics Company Details
    Table 106. Osiris Therapeutics Business Overview
    Table 107. Osiris Therapeutics Regenerative Medicine Product
    Table 108. Osiris Therapeutics Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 109. Osiris Therapeutics Recent Developments
    Table 110. Vcanbio Company Details
    Table 111. Vcanbio Business Overview
    Table 112. Vcanbio Regenerative Medicine Product
    Table 113. Vcanbio Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 114. Vcanbio Recent Developments
    Table 115. CCBC Company Details
    Table 116. CCBC Business Overview
    Table 117. CCBC Regenerative Medicine Product
    Table 118. CCBC Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 119. CCBC Recent Developments
    Table 120. Cytori Company Details
    Table 121. Cytori Business Overview
    Table 122. Cytori Regenerative Medicine Product
    Table 123. Cytori Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 124. Cytori Recent Developments
    Table 125. Celgene Company Details
    Table 126. Celgene Business Overview
    Table 127. Celgene Regenerative Medicine Product
    Table 128. Celgene Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 129. Celgene Recent Developments
    Table 130. Vericel Corporation Company Details
    Table 131. Vericel Corporation Business Overview
    Table 132. Vericel Corporation Regenerative Medicine Product
    Table 133. Vericel Corporation Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 134. Vericel Corporation Recent Developments
    Table 135. Guanhao Biotech Company Details
    Table 136. Guanhao Biotech Business Overview
    Table 137. Guanhao Biotech Regenerative Medicine Product
    Table 138. Guanhao Biotech Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 139. Guanhao Biotech Recent Developments
    Table 140. Mesoblast Company Details
    Table 141. Mesoblast Business Overview
    Table 142. Mesoblast Regenerative Medicine Product
    Table 143. Mesoblast Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 144. Mesoblast Recent Developments
    Table 145. AMAG Pharmaceuticals (CBR) Company Details
    Table 146. AMAG Pharmaceuticals (CBR) Business Overview
    Table 147. AMAG Pharmaceuticals (CBR) Regenerative Medicine Product
    Table 148. AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 149. AMAG Pharmaceuticals (CBR) Recent Developments
    Table 150. ViaCord Company Details
    Table 151. ViaCord Business Overview
    Table 152. ViaCord Regenerative Medicine Product
    Table 153. ViaCord Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 154. ViaCord Recent Developments
    Table 155. CordLife Company Details
    Table 156. CordLife Business Overview
    Table 157. CordLife Regenerative Medicine Product
    Table 158. CordLife Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 159. CordLife Recent Developments
    Table 160. Integra LifeSciences Company Details
    Table 161. Integra LifeSciences Business Overview
    Table 162. Integra LifeSciences Regenerative Medicine Product
    Table 163. Integra LifeSciences Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 164. Integra LifeSciences Recent Developments
    Table 165. Nuvasive Company Details
    Table 166. Nuvasive Business Overview
    Table 167. Nuvasive Regenerative Medicine Product
    Table 168. Nuvasive Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 169. Nuvasive Recent Developments
    Table 170. Cook Biotech Company Details
    Table 171. Cook Biotech Business Overview
    Table 172. Cook Biotech Regenerative Medicine Product
    Table 173. Cook Biotech Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 174. Cook Biotech Recent Developments
    Table 175. Japan Tissue Engineering Company Details
    Table 176. Japan Tissue Engineering Business Overview
    Table 177. Japan Tissue Engineering Regenerative Medicine Product
    Table 178. Japan Tissue Engineering Revenue in Regenerative Medicine Business (2019-2024) & (US$ Million)
    Table 179. Japan Tissue Engineering Recent Developments
    Table 180. Research Programs/Design for This Report
    Table 181. Key Data Information from Secondary Sources
    Table 182. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Regenerative Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Regenerative Medicine Market Share by Type: 2023 VS 2030
    Figure 3. Cell Therapy Features
    Figure 4. Tissue Engineering Features
    Figure 5. Biomaterial Features
    Figure 6. Other Features
    Figure 7. Global Regenerative Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Regenerative Medicine Market Share by Application: 2023 VS 2030
    Figure 9. Dermatology Case Studies
    Figure 10. Cardiovascular Case Studies
    Figure 11. CNS Case Studies
    Figure 12. Orthopedic Case Studies
    Figure 13. Others Case Studies
    Figure 14. Regenerative Medicine Report Years Considered
    Figure 15. Global Regenerative Medicine Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Regenerative Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Regenerative Medicine Market Share by Region: 2023 VS 2030
    Figure 18. Global Regenerative Medicine Market Share by Players in 2023
    Figure 19. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Regenerative Medicine Revenue in 2023
    Figure 21. North America Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Regenerative Medicine Market Share by Type (2019-2030)
    Figure 23. North America Regenerative Medicine Market Share by Application (2019-2030)
    Figure 24. North America Regenerative Medicine Market Share by Country (2019-2030)
    Figure 25. United States Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Canada Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Regenerative Medicine Market Size YoY (2019-2030) & (US$ Million)
    Figure 28. Europe Regenerative Medicine Market Share by Type (2019-2030)
    Figure 29. Europe Regenerative Medicine Market Share by Application (2019-2030)
    Figure 30. Europe Regenerative Medicine Market Share by Country (2019-2030)
    Figure 31. Germany Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. France Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. U.K. Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Italy Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Russia Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Nordic Countries Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. China Regenerative Medicine Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. China Regenerative Medicine Market Share by Type (2019-2030)
    Figure 39. China Regenerative Medicine Market Share by Application (2019-2030)
    Figure 40. Asia Regenerative Medicine Market Size YoY (2019-2030) & (US$ Million)
    Figure 41. Asia Regenerative Medicine Market Share by Type (2019-2030)
    Figure 42. Asia Regenerative Medicine Market Share by Application (2019-2030)
    Figure 43. Asia Regenerative Medicine Market Share by Region (2019-2030)
    Figure 44. Japan Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. South Korea Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. China Taiwan Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. India Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Australia Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Regenerative Medicine Market Size YoY (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Regenerative Medicine Market Share by Type (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Regenerative Medicine Market Share by Application (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Regenerative Medicine Market Share by Country (2019-2030)
    Figure 54. Brazil Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Mexico Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Turkey Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Israel Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. GCC Countries Regenerative Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. J & J (DePuy Synthes) Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 61. Medtronic Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 62. Zimmer Biomet Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 63. Stryker Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 64. Allergan(Acelity) Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 65. MiMedx Group Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 66. Organogenesis Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 67. Fujifilm Cellular Dynamics Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 68. Osiris Therapeutics Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 69. Vcanbio Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 70. CCBC Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 71. Cytori Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 72. Celgene Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 73. Vericel Corporation Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 74. Guanhao Biotech Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 75. Mesoblast Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 76. AMAG Pharmaceuticals (CBR) Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 77. ViaCord Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 78. CordLife Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 79. Integra LifeSciences Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 80. Nuvasive Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 81. Cook Biotech Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 82. Japan Tissue Engineering Revenue Growth Rate in Regenerative Medicine Business (2019-2024)
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed